Blaize Holdings Names Lane Bess as Chairman-March 2024-www.financetom.com

Blaize Holdings Names Lane Bess as Chairman

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Blaize Holdings Names Lane Bess as Chairman

Jan 15, 2025 8:07 AM

10:33 AM EST, 01/15/2025 (MT Newswires) -- Blaize Holdings ( BZAI ) said Wednesday that Lane Bess was appointed as chairman of its board.

Bess is the former chief executive officer of Palo Alto Networks ( PANW ) , according to the statement.

Blaize Holdings ( BZAI ) shares were down more than 6% in recent trading.

Price: 12.29, Change: -0.84, Percent Change: -6.40

Previous page： BioAge targets to raise up to $142.5 mln in US IPO Next page： Vaxcyte Insider Sold Shares Worth $1,159,635, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BioAge targets to raise up to $142.5 mln in US IPO

Sep 22, 2024

Sept 18 (Reuters) - BioAge Labs said on Wednesday it was aiming to raise as much as $142.5 million in its initial public offering in the United States. ...

Vaxcyte Insider Sold Shares Worth $1,159,635, According to a Recent SEC Filing

Sep 22, 2024

04:28 PM EDT, 09/18/2024 (MT Newswires) -- Jim Wassil, COO, on September 16, 2024, sold 10,000 shares in Vaxcyte ( PCVX ) for $1,159,635. Following the Form 4 filing with the SEC, Wassil has control over a total of 200,646 shares of the company, with 200,646 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649094/000164909424000068/xslF345X05/wk-form4_1726691002.xml ...

Hydrofarm Gets Extension From Nasdaq to Regain Compliance With Bid Price Rule

Sep 22, 2024

04:26 PM EDT, 09/18/2024 (MT Newswires) -- Hydrofarm Holdings Group ( HYFM ) said Wednesday it has obtained a 180 calendar day extension, or until March 10, from Nasdaq to regain compliance with the stock exchange's bid price rule. The rule states that the bid price of the company's shares must close at $1 per share or more for a...

A second Zantac cancer trial ends with hung jury

Sep 22, 2024

* Hung jury in latest Zantac cancer trial in Chicago * Boehringer Ingelheim only defendant after settlements with GSK, Pfizer ( PFE ) * FDA pulled Zantac in 2020 over NDMA carcinogen concerns By Brendan Pierson Sept 18 (Reuters) - The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday,...